APA aipamena

Laubach, J. P., Tuchman, S. A., Rosenblatt, J. M., Mitsiades, C. S., Colson, K., Masone, K., . . . Richardson, P. G. (2021). Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma. Blood Cancer J.

Chicago Style aipamena

Laubach, Jacob P., et al. "Phase 1 Open-label Study of Panobinostat, Lenalidomide, Bortezomib + dexamethasone in Relapsed and Relapsed/refractory Multiple Myeloma." Blood Cancer J 2021.

MLA aipamena

Laubach, Jacob P., et al. "Phase 1 Open-label Study of Panobinostat, Lenalidomide, Bortezomib + dexamethasone in Relapsed and Relapsed/refractory Multiple Myeloma." Blood Cancer J 2021.